Table 3.

Self-reported scores of questionnaires assessing quality of life, fatigue, depression, attentions deficits, and pain in association with maximum extent of disease

Self-report (scale)TotalMaximum extent of disease
SSMFBMS RO–MS RO+
NMean (SD)Median (IQR)nMean (SD)Median (IQR)nMean (SD)Median (IQR)nMean (SD)Median (IQR)nMean (SD)Median (IQR)
Total HRQOL score (0-100) 32 78.8 (16.2) 81.0 (91.0-69.2) 13 85.6 (9.3) 88.0 (93.5-78.3) 76.3 (15.4) 81.5 (89.7-60.3) 10 77.7 (18.5) 80.4 (91.0-66.6) 62.7 (21.6) 58.1 (85.3-44.8) 
Quality of life (0-10) 26 6.7 (2.5) 7.0 (9.0-4.8) 11 7.2 (2.3) 8.0 (9.0-6.0) 6.7 (3.5) 7.0 (3.0;10.0)#  5.9 (2.6) 6.3 (7.8-3.5) 6.6 (2.6) 6.5 (9.1-4.3) 
Total Fatigue score (0-100) 30 68.7 (19.8) 68.8 (90.3-55.6) 13 72.5 (16.9) 72.2 (91.7-61.5) 66.3 (19.7) 64.6 (86.1-48.3) 71.0 (18.7) 69.4 (89.6-53.5) 53.8 (30.5) 44.4 (86.1-30.9) 
Depression (MADRS-s)§ 
(0-54) 
26 9.8 (10.0) 7.5 (13.8-2.0) 11 7.9 (8.9) 7.0 (10.0-2.0) 4.7 (3.1) 4.0 (2.0; 8.0)#  11.0 (9.8) 9.5 (20.8-1.5) 16.3 (15.4) 14.0 (31.8-3.0) 
Hyperactivity|| (z score) 32 0.00  13 −0.18 (0.60) −0.53 (−0.46 to −0.67) 0.35 (1.4) 0.09 (1.68 to −0.84) 10 −0.05 (1.05) −0.22 (0.63 to −0.91) 0.29 (1.36) 0.48 (1.48 to −1.1) 
Inattention|| (z score) 32 0.00  13 −0.27 (0.67) −0.12 (0.35 to −0.73) 0.62 (0.94) 0.33 (1.42 to −0.03) 10 −0.18 (1.14) −0.51 (0.82 to −1.12) 0.31 (1.38) 0.6 (1.43 to –1.12) 
Pain (0-10) 21 3.5 (3.2) 5.0 (6.5-0.0) 2.8 (3.4) 0.0 (6.0-0.0) 3.0 (4.2) 3.0 (0.0;6.0)#  3.5 (2.6) 4.0 (6.0-0.8) 5.5 (3.7) 7.0 (7.8-1.8) 
Self-report (scale)TotalMaximum extent of disease
SSMFBMS RO–MS RO+
NMean (SD)Median (IQR)nMean (SD)Median (IQR)nMean (SD)Median (IQR)nMean (SD)Median (IQR)nMean (SD)Median (IQR)
Total HRQOL score (0-100) 32 78.8 (16.2) 81.0 (91.0-69.2) 13 85.6 (9.3) 88.0 (93.5-78.3) 76.3 (15.4) 81.5 (89.7-60.3) 10 77.7 (18.5) 80.4 (91.0-66.6) 62.7 (21.6) 58.1 (85.3-44.8) 
Quality of life (0-10) 26 6.7 (2.5) 7.0 (9.0-4.8) 11 7.2 (2.3) 8.0 (9.0-6.0) 6.7 (3.5) 7.0 (3.0;10.0)#  5.9 (2.6) 6.3 (7.8-3.5) 6.6 (2.6) 6.5 (9.1-4.3) 
Total Fatigue score (0-100) 30 68.7 (19.8) 68.8 (90.3-55.6) 13 72.5 (16.9) 72.2 (91.7-61.5) 66.3 (19.7) 64.6 (86.1-48.3) 71.0 (18.7) 69.4 (89.6-53.5) 53.8 (30.5) 44.4 (86.1-30.9) 
Depression (MADRS-s)§ 
(0-54) 
26 9.8 (10.0) 7.5 (13.8-2.0) 11 7.9 (8.9) 7.0 (10.0-2.0) 4.7 (3.1) 4.0 (2.0; 8.0)#  11.0 (9.8) 9.5 (20.8-1.5) 16.3 (15.4) 14.0 (31.8-3.0) 
Hyperactivity|| (z score) 32 0.00  13 −0.18 (0.60) −0.53 (−0.46 to −0.67) 0.35 (1.4) 0.09 (1.68 to −0.84) 10 −0.05 (1.05) −0.22 (0.63 to −0.91) 0.29 (1.36) 0.48 (1.48 to −1.1) 
Inattention|| (z score) 32 0.00  13 −0.27 (0.67) −0.12 (0.35 to −0.73) 0.62 (0.94) 0.33 (1.42 to −0.03) 10 −0.18 (1.14) −0.51 (0.82 to −1.12) 0.31 (1.38) 0.6 (1.43 to –1.12) 
Pain (0-10) 21 3.5 (3.2) 5.0 (6.5-0.0) 2.8 (3.4) 0.0 (6.0-0.0) 3.0 (4.2) 3.0 (0.0;6.0)#  3.5 (2.6) 4.0 (6.0-0.8) 5.5 (3.7) 7.0 (7.8-1.8) 

MFB, multifocal bone; MS, multisystem, RO+, with risk organ (liver, spleen, and/or hematopoietic system) involvement; RO-, without risk organ involvement; ND-LCH, LCH-associated neurodegeneration.

5-point Likert scale, the PedsQL Generic Core Scale 4.0, ranges from 0 (worst quality of life) to 100 (best quality of life).

Experience the last year on a 10-point scale from 0 (worst possible quality of life) to 10 (best possible quality of life).

5-point Likert scale, the PedsQL Multidimensional Fatigue Scale, ranges from 0 (most fatigue) to 100 (less fatigue).

§

7-point Likert scale, cutoff points are as follows: 0 to 12, no depression; 13 to 19, mild depression; 20 to 34, moderate depression; and ≥35, severe depression.

||

Adult ADHD self-report scales v1.1 (patients ≥18 years) and Conners 3 short form (patients <18 years) transformed to a z score, which compares each individual to the mean of the cohort.

Pain experienced the last year on a 10-point scale from 0 (no pain) to 10 (worst possible pain).

#

min;max.

or Create an Account

Close Modal
Close Modal